Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages

ABSTRACT Objective To investigate which factors are associated with the quality of life decline in Parkinson’s disease patients from mild to moderate stages. Methods The Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease Questionnaire-39 were used to evaluate clinical/functional da...

Full description

Bibliographic Details
Main Authors: Raissa Carla Moreira, Marise Bueno Zonta, Ana Paula Serra de Araújo, Vera Lúcia Israel, Hélio A. G. Teive
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO)
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800497&lng=en&tlng=en
id doaj-0024fa99a66b4a33b1aff83f82440160
record_format Article
spelling doaj-0024fa99a66b4a33b1aff83f824401602020-11-24T22:41:32ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-422775849750210.1590/0004-282x20170091S0004-282X2017000800497Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stagesRaissa Carla MoreiraMarise Bueno ZontaAna Paula Serra de AraújoVera Lúcia IsraelHélio A. G. TeiveABSTRACT Objective To investigate which factors are associated with the quality of life decline in Parkinson’s disease patients from mild to moderate stages. Methods The Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease Questionnaire-39 were used to evaluate clinical/functional data and the quality of life. Results The markers of clinical/functional worsening were drooling (p < 0.004), need for assistance with hygiene (p = 0.02), greater freezing frequency (p = 0.042), bradykinesia (p = 0.031), greater intensity of the resting tremor (p = 0.035) and “pill rolling” (p = 0.001). The decline in quality of life was related to stigma (p = 0.043), greater impairment in cognition (p = 0.002), mobility (p = 0.013) and for daily living activities (p = 0.05), and was considered more significant in men, married, older individuals, and those with a longer time of disease. Conclusions The quality of life worsening markers at the moderate stage were related to stigma, worsening of cognition, and to greater impairment in mobility and daily living activities.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800497&lng=en&tlng=enParkinson diseasequality of lifesurveys and questionnaires
collection DOAJ
language English
format Article
sources DOAJ
author Raissa Carla Moreira
Marise Bueno Zonta
Ana Paula Serra de Araújo
Vera Lúcia Israel
Hélio A. G. Teive
spellingShingle Raissa Carla Moreira
Marise Bueno Zonta
Ana Paula Serra de Araújo
Vera Lúcia Israel
Hélio A. G. Teive
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
Arquivos de Neuro-Psiquiatria
Parkinson disease
quality of life
surveys and questionnaires
author_facet Raissa Carla Moreira
Marise Bueno Zonta
Ana Paula Serra de Araújo
Vera Lúcia Israel
Hélio A. G. Teive
author_sort Raissa Carla Moreira
title Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
title_short Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
title_full Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
title_fullStr Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
title_full_unstemmed Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
title_sort quality of life in parkinson’s disease patients: progression markers of mild to moderate stages
publisher Academia Brasileira de Neurologia (ABNEURO)
series Arquivos de Neuro-Psiquiatria
issn 1678-4227
description ABSTRACT Objective To investigate which factors are associated with the quality of life decline in Parkinson’s disease patients from mild to moderate stages. Methods The Unified Parkinson’s Disease Rating Scale and Parkinson’s Disease Questionnaire-39 were used to evaluate clinical/functional data and the quality of life. Results The markers of clinical/functional worsening were drooling (p < 0.004), need for assistance with hygiene (p = 0.02), greater freezing frequency (p = 0.042), bradykinesia (p = 0.031), greater intensity of the resting tremor (p = 0.035) and “pill rolling” (p = 0.001). The decline in quality of life was related to stigma (p = 0.043), greater impairment in cognition (p = 0.002), mobility (p = 0.013) and for daily living activities (p = 0.05), and was considered more significant in men, married, older individuals, and those with a longer time of disease. Conclusions The quality of life worsening markers at the moderate stage were related to stigma, worsening of cognition, and to greater impairment in mobility and daily living activities.
topic Parkinson disease
quality of life
surveys and questionnaires
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800497&lng=en&tlng=en
work_keys_str_mv AT raissacarlamoreira qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages
AT marisebuenozonta qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages
AT anapaulaserradearaujo qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages
AT veraluciaisrael qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages
AT helioagteive qualityoflifeinparkinsonsdiseasepatientsprogressionmarkersofmildtomoderatestages
_version_ 1725702034491965440